Overview

An Investigational Drug Study in Patients With Type 2 Diabetes Mellitus (MK0431-023)

Status:
Completed
Trial end date:
2006-04-28
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety and effectiveness of an investigational drug in patients with Type 2 Diabetes Mellitus.
Phase:
Phase 3
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Pioglitazone
Sitagliptin Phosphate